Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
Fondazione IRCCS Istituto Nazionale dei Tumori · Olgahospital · +12 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,264
total citations
- FWCI
- 48.20
- Percentile
- 100%
- References
- 36
Citations per year
Authors
20Topics & keywords
Topics
Keywords
- Trastuzumab
- Medicine
- Breast cancer
- Oncology
- Internal medicine
- Regimen
- Chemotherapy
- Hazard ratio
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.